CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Medical Devices (6162)
Endomedix develops hydrogel technology within the medical device market. At the core of Endomedix's technology is a biocompatible, biodegradable, environmentally-responsive hydrogel with a number of biomedical applications.
Company (Alive / Active)
Phone: 848-248-1883
1 Normal Avenue
CELS 404
Montclair, 07043`
New Jersey, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| EndoMedix | $1.5M | May 15, 2019 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods and compositions for achieving hemostasis and stable blood clot formation | Nov 19, 2018 | Dec 31, 2019 | Patent |
| Biopolymer system for tissue sealing | Jan 21, 2016 | Aug 15, 2017 | Patent |
| Biopolymer system for tissue sealing | Jul 16, 2013 | Feb 16, 2016 | Patent |
| Biopolymer system for tissue sealing | Sep 15, 2010 | Aug 20, 2013 | Patent |
| Biopolymer system for tissue sealing | Sep 08, 2006 | Dec 21, 2010 | Patent |
